LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0

Historical Holders from Q4 2015 to Q4 2021

Type / Class
Debt / NOTE 5.250%12/0
All holders as of 31 Dec 2021
Q4 2021
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-5
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0

Period Principal Value Change Price Investors
2021 Q4 0 $0 -$11,722,020 0
2021 Q3 11,630,000 $11,722,020 $1.01 5
2021 Q2 11,630,000 $11,690,752 $1 5
2021 Q1 11,630,000 $12,572,059 $1.1 5
2020 Q4 11,630,000 $10,188,999 $0.8666 5
2020 Q3 11,630,000 $9,290,664 -$12,189,375 $0.7888 5
2020 Q2 32,839,000 $14,774,121 $0.4075 8
2020 Q1 90,639,000 $47,089,416 $0.48 12
2019 Q4 88,139,000 $66,588,984 -$77,014 $0.7417 11
2019 Q3 88,239,000 $58,179,340 $0.6578 11
2019 Q2 88,239,000 $95,335,801 +$253,292 $1.07 11
2019 Q1 88,209,000 $89,933,200 -$93,250 $1.01 11
2018 Q4 88,209,000 $98,475,785 $1.12 10
2018 Q3 87,209,000 $129,842,575 $1.49 9
2018 Q2 87,209,000 $140,276,471 +$9,641 $1.61 9
2018 Q1 87,209,000 $113,493,235 -$386,757 $1.3 9
2017 Q4 87,500,000 $124,162,001 $1.42 7
2017 Q3 87,500,000 $144,625,500 -$14,131 $1.63 7
2017 Q2 87,500,000 $182,446,200 +$658,919 $2.08 8
2017 Q1 87,500,000 $163,115,080 +$1,533,106 $1.86 7
2016 Q4 87,500,000 $157,420,000 -$46,449 $1.8 9
2016 Q3 87,500,000 $198,101,000 +$5,099,540 $2.26 9
2016 Q2 87,625,000 $164,382,000 +$3,194,558 $1.88 12
2016 Q1 87,500,000 $141,157,000 +$3,228,692 $1.61 12
2015 Q4 85,350,000 $149,424,000 +$135,370,000 $1.75 12